(Q48392689)

11 February 2018

title

Extracorporeal photochemotherapy as systemic monotherapy of severe, refractory atopic dermatitis: results from a prospective trial. (English)

1 reference

11 February 2018

1 reference

Peter Wolf

1

1 reference

11 February 2018

Dimitrios Georgas

2

1 reference

11 February 2018

Nordwig S Tomi

3

1 reference

11 February 2018

Christoph M Schempp

4

1 reference

11 February 2018

Klaus Hoffmann

5

1 reference

11 February 2018

publication date

1 January 2013

1 reference

11 February 2018

Photochemical and Photobiological Sciences

published in

1 reference

11 February 2018

volume

12

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

174-181

1 reference

11 February 2018

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Guidelines for management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

T regulatory cells in atopic dermatitis and subversion of their activity by superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Development and function of TH17 cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Soluble interleukin 2 receptor in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Management of atopic dermatitis using photo(chemo)therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Treatment of severe atopic dermatitis with extracorporeal photopheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis. An Austrian single-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Life quality assessment among patients with atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Extracorporeal photoimmunotherapy-photopheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Extracorporeal photopheresis: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Photopheresis in the red man or pre-Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Regulation of cellular immunity by Photo(chemo)therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Leucocyte scintigraphy with 111In-oxine for assessment of cell trafficking after extracorporeal photopheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

The pro-inflammatory role of TGFβ1: a paradox?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2PP25203A

21 January 2018

Identifiers

DOI

10.1039/C2PP25203A

1 reference

11 February 2018

PubMed ID

22948099

1 reference

11 February 2018